Charitable Contributions & Sponsorships Taiho Oncology is honored to be able to provide support to external, independent, not-for-profit organizations that help build, educate, and improve the lives of patients with cancer. These organizations can include patient advocacy groups and patient-focused charitable organizations.
Apply

PROVIDING FUNDING OPPORTUNITIES FOR CHARITABLE CONTRIBUTIONS & SPONSORSHIPS

Charitable Contribution

Charitable Contribution ("Charitable Contribution") means donations to support the general activities of a 501(c)(3) registered tax exempt organization engaged in healthcare-related purposes. Please review the request process below for more information.

Charitable Contributions by Taiho Oncology are only provided in response to an unsolicited written request, are not conditioned on the use, purchase, prescription or recommendation of any Taiho Oncology product.

Request a Charitable Contribution or view the status of your existing request via Taiho Oncology's online portal.

Sponsorships

Taiho Oncology will consider requests for patient support activities that benefit patients, families, or caregivers and are consistent with Taiho Oncology's scientific and disease state interests.

Sponsorship ("Sponsorship") means supporting an activity where Taiho Oncology may receive a tangible benefit (including but not limited to signage, booth space, recognition logo on website or in activity materials, etc.) in exchange for financial support. The requests must be aligned with Taiho Oncology's areas of focus and be submitted by a non-promotional, healthcare related organization such as medical or academic institutions, scientific or professional associations, patient advocacy groups, or medical education companies. Funding must be requested from multiple supporters, and must seek to advance science or medicine.

Charitable Contributions and Sponsorships by Taiho Oncology are only provided in response to an unsolicited written request, and not conditioned on the use, purchase, prescribe, or recommendation of any Taiho Oncology product.

Submissions are accepted on an ongoing basis and must align with our areas of interest in Aesthetics, Consumer Care and Prescription medicine. Only products approved by the U.S. Food and Drug Administration may be provided to support IISs. To view our current areas of interest and portfolio of products available for request, please visit www.Taiho.com/us.

REQUESTS THAT WILL BE CONSIDERED

The following IIS study types may be considered for support:

Prospective clinical or preclinical studies involving Taiho products
Non-interventional research, such as epidemiology or outcomes studies, where the focus is on scientific understanding of the disease
In vitro and in vivo studies

REQUESTS THAT WILL NOT BE CONSIDERED

We do not provide support for the following:

Proposals that are not aligned with our current areas of interest
Studies that have already started or are completed
Proposals that are conditioned upon past or future prescriptions or purchases of Taiho products
Requests that create a conflict of interest for Taiho

REQUEST PROCESS

Requests for support may only be submitted through Taiho Oncology's Charitable Contributions online portal at least sixty (60) days prior to the program.

A Request must include the following:

Letter of Request on the organization's official letterhead.
Program Proposal and/or Brochure on the organization's official letterhead.
Proposed Budget.
Completed W-9 Form.
IRS Letter of Determination confirming the organization's 501(c)(3) and 501(c)(6) tax exempt status within the United States (or W8-BEN status if not located in the United States).
Most recent IRS Form 990. (US only)

After Taiho Oncology has received the request, an electronic notification will be sent to the contact listed in the request confirming receipt.

After receiving an acknowledgement of receipt, you will receive subsequent communication about the status of the request.

We will consider reasonable requests for funding in support of an IIS. All full proposal submissions must include an itemized budget with costs based on fair market value (FMV) evaluations to ensure that the amount of support is appropriate. Requestors may use their own template or the Taiho template that is provided here. Line item allocations should be specified for each aspect of the study, such as study start-up fees (e.g., IRB submission), study visits (e.g., physical exam, vital signs, pregnancy test), and publication costs (e.g., medical writer).

For study-specific items, or equipment that may be required, please provide a rental estimate from a vendor of choice. Please note that we do not provide support for the following:

Salary and/or benefit payments for Investigators or study staff
Education/training activities
Costs that are deemed in excess of fair market value
Capital equipment purchases (associated rental fees will be considered)
Construction funds to build new facilities

FREQUENTLY ASKED QUESTIONS

HOW DO I CREATE AN ACCOUNT?

Follow instructions provided on the HOW TO APPLY tab, or you may access the user guide for additional guidance.
Click on CREATE ACCOUNT in the top menu, or download the user guide for additional information.

HOW DO I RESET MY PASSWORD?

Use the "Forgot Password?" link to reset your password.
If you do not receive the password reset email in your inbox, please check your Junk or Spam folder.

HOW DO I KNOW IF MY SUBMISSION IS APPROVED?

You may view the status of your submission via the MY SUBMISSIONS tab after you've logged into your account.

We are committed to maintaining integrity in all of our professional relationships. We operate under the highest ethical standards and in full compliance with all applicable laws, regulations, industry codes, and guidelines. Approval of IIS support is never related to or conditioned upon past or future prescriptions or purchases of Taiho products. Furthermore, we do not offer, or provide funding to encourage or to reward the prescription, purchase, ordering, or recommending of Taiho products.

Our grant review and approval process is in full accordance with the recommendations and the guidance of the U.S. Food and Drug Administration (FDA), the Pharmaceutical Research and Manufacturers Association (PhRMA), the Office of Inspector General (OIG) Compliance Program Guidance for Pharmaceutical Manufacturers, the PhRMA Code on Interaction with Health Care Professionals, the AdvaMed Code of Ethics on Interactions with Health Care Providers, and National Physician Payment Transparency Program: Open Payments "Physician Payment Sunshine Act", as well as internal Taiho policies.

Submission Confidentiality

By submitting materials for review, you agree that the information is not confidential, nor proprietary, and may be referred to a number of different persons at Taiho to determine the level of interest in supporting your request.

Disclosure of Support

Publications or other presentation of data derived from the IIS must be marked with an acknowledgement that the study was conducted with financial and/or in-kind support from Taiho, as a collaborator.